butabarbital decreases effects of sufentanil SL by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Keep an eye on Carefully. Coadministration of CYP3A4 inducers may well decrease sufentanil ranges and efficacy, possibly precipitating withdrawal syndrome in individuals who have designed Actual physical dependence to sufentanil.